13 years 🥳 of Publication, 100k+ Stories, 30+ Countries
Search
The Latest News from All Areas of Deals
Latham & Watkins Advises on Axonics’ US$3.7 Billion Acquisition by Boston Scientific
Axonics, Inc. (Nasdaq: AXNX) has announced that it has entered into a definitive agreement to be acquired by Boston Scientific…
Latham Advises IKS on Financing for Acquisition of AQuity Holdings
Latham & Watkins has advised IKS, a premier global healthcare solution provider, on the financing for the acquisition of AQuity…
Latham Advises Rhythm on Agreement to Acquire Global Rights to Oral MC4R Agonist LB54640 From LG Chem
Latham & Watkins has advised Rhythm Pharmaceuticals, Inc. (Rhythm), a global commercial-stage biopharmaceutical company focused on transforming the lives of…
Linklaters advises Hg in relation to its investment in IRIS, representing one of Europe’s largest software buyouts for 2023
Linklaters has advised Hg, a leading investor in European and transatlantic software and services businesses, in relation to its re-investment…
Sidley Advises Stonepeak on Its Agreement With the AA and the AA’s Majority Shareholders, TowerBrook Capital Partners, and Warburg Pincus
Sidley is advising Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, on its agreement with the…
Sidley Represented Resolian in its Acquisition of China-Based Bioanalytical CRO Denali Medpharma
Sidley represented Resolian, a global bioanalytical contract research organization (CRO) specializing in drug metabolism and pharmacokinetics for small and large…
